166 related articles for article (PubMed ID: 22744981)
1. Using a 2D multibreath-hold susceptibility-weighted imaging to visualize intratumoral hemorrhage of hepatocellular carcinoma at 3T MRI: correlation with pathology.
Li RK; Zeng MS; Rao SX; Qiang JW; Dai YM; Ji Y; Chen CZ; Renate J
J Magn Reson Imaging; 2012 Oct; 36(4):900-6. PubMed ID: 22744981
[TBL] [Abstract][Full Text] [Related]
2. Characterizing hepatocellular carcinoma using multi-breath-hold two-dimensional susceptibility-weighted imaging: comparison to conventional liver MRI.
Tao R; Zhang J; Dai Y; You Z; Fan Y; Cui J; Wang J
Clin Radiol; 2012 Dec; 67(12):e91-7. PubMed ID: 22981726
[TBL] [Abstract][Full Text] [Related]
3. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
4. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
5. The use of T2*-weighted multi-echo GRE imaging as a novel method to diagnose hepatocellular carcinoma compared with gadolinium-enhanced MRI: a feasibility study.
Hardie AD; Romano PB
Magn Reson Imaging; 2010 Feb; 28(2):281-5. PubMed ID: 20071122
[TBL] [Abstract][Full Text] [Related]
6. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid-enhanced fat suppressed three-dimensional T1-weighted MRI using a multiecho dixon technique at 3 tesla: emphasis on image quality and hepatocellular carcinoma detection.
Lee MH; Kim YK; Park MJ; Hwang J; Kim SH; Lee WJ; Choi D
J Magn Reson Imaging; 2013 Aug; 38(2):401-10. PubMed ID: 23292998
[TBL] [Abstract][Full Text] [Related]
8. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value?
Guo L; Liang C; Yu T; Wang G; Li N; Sun H; Gao F; Liu C
Clin Radiol; 2012 Apr; 67(4):319-28. PubMed ID: 22099524
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility-weighted imaging in grading brain astrocytomas.
Li C; Ai B; Li Y; Qi H; Wu L
Eur J Radiol; 2010 Jul; 75(1):e81-5. PubMed ID: 19726149
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatocellular carcinoma (HCC) using super paramagnetic iron oxide (SPIO)-enhanced MRI: Added value of diffusion-weighted imaging (DWI).
Nishie A; Tajima T; Ishigami K; Ushijima Y; Okamoto D; Hirakawa M; Nishihara Y; Taketomi A; Hatakenaka M; Irie H; Yoshimitsu K; Honda H
J Magn Reson Imaging; 2010 Feb; 31(2):373-82. PubMed ID: 20099351
[TBL] [Abstract][Full Text] [Related]
12. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility-weighted imaging: the value in cerebral astrocytomas grading.
Zhang H; Tan Y; Wang XC; Qing JB; Wang L; Wu XF; Zhang L; Liu QW
Neurol India; 2013; 61(4):389-95. PubMed ID: 24005730
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction.
Kim S; Mannelli L; Hajdu CH; Babb JS; Clark TW; Hecht EM; Taouli B
J Magn Reson Imaging; 2010 Feb; 31(2):348-55. PubMed ID: 20099348
[TBL] [Abstract][Full Text] [Related]
15. Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features.
Kim JY; Kim MJ; Kim KA; Jeong HT; Park YN
Eur J Radiol; 2012 Dec; 81(12):3877-82. PubMed ID: 22954410
[TBL] [Abstract][Full Text] [Related]
16. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
[TBL] [Abstract][Full Text] [Related]
17. MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm.
Choi MH; Choi JI; Lee YJ; Park MY; Rha SE; Lall C
AJR Am J Roentgenol; 2017 Mar; 208(3):544-551. PubMed ID: 28026208
[TBL] [Abstract][Full Text] [Related]
18. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
[TBL] [Abstract][Full Text] [Related]
19. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence.
Fütterer JJ; Yakar D; Strijk SP; Barentsz JO
Eur J Radiol; 2008 Jan; 65(1):66-71. PubMed ID: 18164156
[TBL] [Abstract][Full Text] [Related]
20. Small hepatocellular carcinoma: MRI findings for predicting tumor growth rates.
Jha RC; Zanello PA; Nguyen XM; Pehlivanova M; Johnson LB; Fishbein T; Shetty K
Acad Radiol; 2014 Nov; 21(11):1455-64. PubMed ID: 25300723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
